T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.79B |
| 2 |
PayPal
PYPL
|
+$1.64B |
| 3 |
Alibaba
BABA
|
+$1.46B |
| 4 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$1.11B |
| 5 |
Johnson Controls International
JCI
|
+$1.09B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TotalEnergies
TTE
|
+$8.15B |
| 2 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
+$1.77B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.74B |
| 4 |
Danaher
DHR
|
+$1.54B |
| 5 |
GE Aerospace
GE
|
+$1.26B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.56% |
| 2 | Consumer Discretionary | 15.28% |
| 3 | Financials | 14.93% |
| 4 | Technology | 13.43% |
| 5 | Communication Services | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Trustmark
TRMK
$2.8B
| $1.03M | ﹤0.01% |
37,429
| – | – |
|
1727
Pilgrim's Pride
PPC
$6.57B
| $1.03M | ﹤0.01% |
+48,656
| New | +$1.13M |
|
|
CSR
1728
Centerspace
CSR
$939M
| $1.02M | ﹤0.01% |
17,205
+1,105
| +7% | +$70.4K |
|
1729
UMB Financial
UMBF
$11.5B
| $1.02M | ﹤0.01% |
17,232
-16
| -0.1% | -$916 |
|
|
EFII
1730
DELISTED
Electronics for Imaging
EFII
| $1.02M | ﹤0.01% |
20,930
-17
| -0.1% | -$777 |
|
|
ODP
1731
DELISTED
ODP
ODP
| $1.02M | ﹤0.01% |
28,654
-20
| -0.1% | -$709 |
|
|
PDM
1732
Piedmont Realty Trust
PDM
$1.2B
| $1.02M | ﹤0.01% |
46,827
+2,770
| +6% | +$59.5K |
|
1733
MillerKnoll
MLKN
$1.62B
| $1.02M | ﹤0.01% |
35,516
+5,116
| +17% | +$169K |
|
|
BCPC
1734
Balchem Corp
BCPC
$5.65B
| $1.01M | ﹤0.01% |
13,078
+2,248
| +21% | +$149K |
|
1735
Liberty Broadband Class A
LBRDA
$5.29B
| $1.01M | ﹤0.01% |
14,419
+10
| +0.1% | +$659 |
|
1736
Sinclair Inc
SBGI
$1.03B
| $1.01M | ﹤0.01% |
34,980
+12,400
| +55% | +$359K |
|
|
MNR
1737
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $1.01M | ﹤0.01% |
70,682
| – | – |
|
|
AERI
1738
DELISTED
Aerie Pharmaceuticals
AERI
| $1.01M | ﹤0.01% |
+26,660
| New | +$588K |
|
|
DNR
1739
DELISTED
Denbury Resources, Inc.
DNR
| $993K | ﹤0.01% |
307,571
-3,803
| -1% | -$11.6K |
|
1740
Renasant Corp
RNST
$4B
| $988K | ﹤0.01% |
29,367
-200
| -0.7% | -$6.71K |
|
1741
PENN Entertainment
PENN
$2.53B
| $987K | ﹤0.01% |
72,754
| – | – |
|
1742
AMN Healthcare
AMN
$1.34B
| $984K | ﹤0.01% |
30,877
+6,600
| +27% | +$251K |
|
|
ARRY
1743
DELISTED
Array Biopharma Inc
ARRY
| $980K | ﹤0.01% |
+145,172
| New | +$561K |
|
|
WAGE
1744
DELISTED
WageWorks, Inc.
WAGE
| $975K | ﹤0.01% |
16,001
-13
| -0.1% | -$797 |
|
1745
Crane NXT
CXT
$2.96B
| $973K | ﹤0.01% |
44,463
+1,157
| +3% | +$24.9K |
|
1746
CoreCivic
CXW
$3.13B
| $966K | ﹤0.01% |
69,681
+10,911
| +19% | +$260K |
|
|
USG
1747
DELISTED
Usg
USG
| $965K | ﹤0.01% |
37,345
-6,100
| -14% | -$169K |
|
1748
Eagle Bancorp
EGBN
$877M
| $959K | ﹤0.01% |
+19,440
| New | +$976K |
|
|
UNT
1749
DELISTED
UNIT Corporation
UNT
| $958K | ﹤0.01% |
51,520
-11,580
| -18% | -$179K |
|
1750
Huntsman Corp
HUN
$1.81B
| $956K | ﹤0.01% |
58,754
-28,400
| -33% | -$450K |
|
Similar funds
T. Rowe Price Associates's Q3 2016 Portfolio in Review
As of Q3 2016, T. Rowe Price Associates held 2,648 positions worth $498B, up 5.4% from $472B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
T. Rowe Price Associates's Q3 2016 filing shows 135 new, 1,180 increased, 817 reduced and 125 closed positions. Its largest new stake was Fortive: 55,770,886 shares worth $1.79B. The largest sale was TotalEnergies, an estimated $8.15B.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2016 buy was Fortive: 55,770,886 shares worth $1.79B.
- T. Rowe Price Associates added most to PayPal in Q3 2016, an estimated $1.64B increase.
- T. Rowe Price Associates's biggest Q3 2016 reduction was TotalEnergies, cutting an estimated $8.15B.
- T. Rowe Price Associates fully exited TYCO INTL PLC COM SHS (IRL) in Q3 2016, selling an estimated $1.77B.
- T. Rowe Price Associates's ten largest holdings make up 17% of its $498B portfolio in Q3 2016.
- T. Rowe Price Associates opened 135 new positions and closed 125 in Q3 2016.
- T. Rowe Price Associates's portfolio value rose 5.4% quarter-over-quarter to $498B.
Based on T. Rowe Price Associates's 13F filing for Q3 2016, filed 14 Nov 2016.